Lmo3-KO 基因敲除小鼠

1. Xu, Wenchao, Sun, Taotao, Wang, Jiaxin, Liu, Jihong, Jiang, Hongyang. 2022. LMO3 downregulation in PCa: A prospective biomarker associated with immune infiltration. In Frontiers in genetics, 13, 945151. doi:10.3389/fgene.2022.945151. https://pubmed.ncbi.nlm.nih.gov/36199576/

2. Wagner, Gabriel, Fenzl, Anna, Lindroos-Christensen, Josefine, Esterbauer, Harald, Bilban, Martin. 2021. LMO3 reprograms visceral adipocyte metabolism during obesity. In Journal of molecular medicine (Berlin, Germany), 99, 1151-1171. doi:10.1007/s00109-021-02089-9. https://pubmed.ncbi.nlm.nih.gov/34018016/

3. Ling, Zeyi, Long, Xiaoli, Wu, Ying, Li, Jie, Feng, Mingliang. 2022. LMO3 promotes proliferation and metastasis of papillary thyroid carcinoma cells by regulating LIMK1-mediated cofilin and the β-catenin pathway. In Open medicine (Warsaw, Poland), 17, 453-462. doi:10.1515/med-2022-0419. https://pubmed.ncbi.nlm.nih.gov/35350839/

4. Reisinger, Sonali N, Bilban, Martin, Stojanovic, Tamara, Boehm, Stefan, Pollak, Daniela D. 2019. Lmo3 deficiency in the mouse is associated with alterations in mood-related behaviors and a depression-biased amygdala transcriptome. In Psychoneuroendocrinology, 111, 104480. doi:10.1016/j.psyneuen.2019.104480. https://pubmed.ncbi.nlm.nih.gov/31707294/

5. Isogai, Eriko, Okumura, Kazuhiro, Saito, Megumi, Nagase, Hiroki, Wakabayashi, Yuichi. 2015. Oncogenic Lmo3 cooperates with Hen2 to induce hydrocephalus in mice. In Experimental animals, 64, 407-14. doi:10.1538/expanim.15-0026. https://pubmed.ncbi.nlm.nih.gov/26156403/

6. Dupain, Célia, Gracia, Céline, Harttrampf, Anne C, Geoerger, Birgit, Massaad-Massade, Liliane. 2019. Newly identified LMO3-BORCS5 fusion oncogene in Ewing sarcoma at relapse is a driver of tumor progression. In Oncogene, 38, 7200-7215. doi:10.1038/s41388-019-0914-3. https://pubmed.ncbi.nlm.nih.gov/31488873/

7. Qiu, Yan-Song, Jiang, Ning-Ning, Zhou, Yan, Gong, Hong-Yan, Liao, Guang-Jun. 2018. LMO3 promotes gastric cancer cell invasion and proliferation through Akt-mTOR and Akt-GSK3β signaling. In International journal of molecular medicine, 41, 2755-2763. doi:10.3892/ijmm.2018.3476. https://pubmed.ncbi.nlm.nih.gov/29436606/

8. Zhang, Yin, An, Jiayin, Pei, Yuchun. 2020. LncRNA SNHG6 promotes LMO3 expression by sponging miR-543 in glioma. In Molecular and cellular biochemistry, 472, 9-17. doi:10.1007/s11010-020-03772-0. https://pubmed.ncbi.nlm.nih.gov/32613482/

9. Ohara, Yuuki, Craig, Amanda J, Liu, Huaitian, Ambs, Stefan, Hussain, S Perwez. . LMO3 is a suppressor of the basal-like/squamous subtype and reduces disease aggressiveness of pancreatic cancer through glycerol 3-phosphate metabolism. In Carcinogenesis, 45, 475-486. doi:10.1093/carcin/bgae011. https://pubmed.ncbi.nlm.nih.gov/38366633/

10. Cheng, Yang, Hou, Tianlu, Ping, Jian, Chen, Tianyang, Yin, Baobing. 2018. LMO3 promotes hepatocellular carcinoma invasion, metastasis and anoikis inhibition by directly interacting with LATS1 and suppressing Hippo signaling. In Journal of experimental & clinical cancer research : CR, 37, 228. doi:10.1186/s13046-018-0903-3. https://pubmed.ncbi.nlm.nih.gov/30219064/